FDA Considers Regulating GenAI Medical Devices Like Clinicians
HealthcareAIGuy · x · 2026-08-22
The FDA is proposing a "competency-based" approach to regulate generative AI medical devices, treating them more like clinicians than traditional software. This involves assessing what models can reliably do before approval and monitoring their performance post-deployment.
More from Safety
- Richard Ngo 谈 MATS 导师选择标准：重思考清晰度 — RichardMCNgo · 2026-08-22
- Dutch Regulator Fines Uber €825M Over Automated Driver Suspensions — Polymarket · 2026-08-22
- Expert Witness Used ChatGPT to Write Report Defending 3M in Deadly Explosion Lawsuit — CackleRooster · 2026-08-22
- Wormable RCE Vulnerabilities Found in Unitree Robots — matthew_d_green · 2026-08-22
- NVIDIA on Agent Security: Harness Guides Intent, Infra Controls Actions — NVIDIAAI · 2026-08-22
- Expert Argues for Stronger Guardrails for AI Bypassing Security Tests — TechNadu · 2026-08-22